术者行大剂量布比卡因关节周围注射联合关节内隐神经阻滞不劣于收肌管阻滞
一项回顾性双术者队列研究比较全膝关节置换术后两种镇痛方法:50例接受术者行大剂量布比卡因关节周围注射联合关节内隐神经阻滞,50例接受麻醉医生行收肌管导管阻滞。结果显示关节周围注射组在麻醉后监护室和病房 arrival 时疼痛评分更低,手术当天静脉阿片类药物用量更少,但术后第1天疼痛评分、总阿片用量、出院时间和短期并发症无显著差异,且无局部麻醉药全身毒性事件。
要点
- 术者行关节周围注射联合关节内隐神经阻滞在手术当天疼痛控制优于收肌管导管。
- 两组术后第1天疼痛评分、总阿片用量、出院时间及短期并发症无显著差异。
- 大剂量布比卡因(60 mL 0.5%)未观察到局部麻醉药全身毒性等心血管并发症。
核心结论
- 与术后收肌管阻滞导管相比,术中行大剂量关节周围注射联合关节内隐神经阻滞在手术当天疼痛评分更低且静脉阿片用量更少。
- 两组在术后第1天疼痛评分、出院时间或并发症方面无差异。
- 尽管注射大剂量布比卡因,未观察到局部麻醉药全身毒性等心血管并发症。
研究设计与样本
- 回顾性双术者队列研究,比较初次全膝关节置换术后短期围手术期结局。
- 术者行大剂量关节周围注射联合关节内隐神经阻滞组50例:60 mL 0.5%布比卡因、30 mL生理盐水、30 mg酮咯酸。
- 麻醉医生行收肌管导管组50例:术后超声引导下置管,0.25%布比卡因以6 mL/h输注泵给药。
- 通过病历回顾评估至术后第1天的疼痛评分、阿片使用、住院时间及短期并发症(包括局部麻醉药全身毒性)。
- 统计分析采用双尾Student's T检验。
主要发现
- 关节周围注射组在麻醉后监护室疼痛评分显著更低(平均差异1.4,P = .035)。
- 关节周围注射组到达住院病房时疼痛评分显著更低(平均差异1.7,P = .013)。
- 关节周围注射组手术当天静脉麻醉药用量更少(平均差异6.5 MME,P = .0004)。
- 术后第1天疼痛评分、总阿片用量、出院日或短期并发症无显著差异。
- 未发生与高剂量布比卡因相关的不良事件。
临床怎么用
- 对于初次全膝关节置换术,可考虑由术者行大剂量关节周围注射联合关节内隐神经阻滞以改善手术当天镇痛并减少静脉阿片用量。
- 该技术可作为收肌管阻滞导管的替代方案,但需注意证据等级为III级。
局限性
- 回顾性队列设计,证据等级为III级。
- 样本量较小(每组50例),可能不足以检测术后第1天疼痛评分、总阿片用量或出院时间的差异。
- 仅由两名术者实施,结果的外推性可能受限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Periarticular injection or anesthesiologist-performed adductor canal block are commonly used for pain management after total knee arthroplasty. A surgeon-performed, intra-articular saphenous nerve block has been recently described. There is insufficient data comparing the efficacy and safety of these methods. METHODS: This is a retrospective two-surgeon cohort study comparing short-term perioperative outcomes after primary total knee arthroplasty, in 50 consecutive patients with surgeon-performed high-dose periarticular injection and intra-articular saphenous nerve block (60 mL 0.5% bupivacaine, 30 mL saline, 30mg ketorolac) and 50 consecutive patients with anesthesiologist-performed adductor canal catheter (0.25% bupivacaine 6 mL/h infusion pump placed postoperatively with ultrasound guidance). Chart review assessed pain scores through POD #1, opioid use, length of stay, and short-term complications, including local anesthetic systemic toxicity. Statistical analysis was performed with two-tailed Student's T-test. RESULTS: The high-dose periarticular injection cohort had significantly lower pain scores in the postanesthesia care unit (mean difference 1.4, P = .035), on arrival to the inpatient ward (mean difference 1.7, P = .013), and required less IV narcotics on the day of surgery (mean difference 6.5 MME, P = .0004). There was no significant difference in pain scores on POD #1, total opioid use, day of discharge, or short-term complications. There were no adverse events related to the high dose of bupivacaine. CONCLUSION: Compared with postoperative adductor canal block catheter, an intraoperative high-dose periarticular block demonstrated lower pain scores and less IV narcotic use on the day of surgery. No difference was noted in pain scores on POD #1, time to discharge, or complications. There were no cardiovascular complications (local anesthetic systemic toxicity) despite the high dose of bupivacaine injected. LEVEL OF EVIDENCE: III.
引用
- Peterson JR, Steele JR, Wellman SS, et al. Surgeon-Performed High-Dose Bupivacaine Periarticular Injection With Intra-Articular Saphenous Nerve Block Is Not Inferior to Adductor Canal Block in Total Knee Arthroplasty. J Arthroplasty. 2020. PMID: 32057598. doi:10.1016/j.arth.2020.01.030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。